Clinical trials
Phase 2 Non-Muscle Invasive Bladder Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 1 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 4 |
| Recruiting | 4 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Completed | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 1 |
| First Affiliated Hospital of Wenzhou Medical University | 1 |
| Fudan University | 1 |
| Fujian Medical University Union Hospital | 1 |
| Janssen Research & Development, LLC | 1 |
| Lepu Biopharma Co., Ltd. | 1 |
| Qilu Hospital of Shandong University | 1 |
| Ractigen Therapeutics. | 1 |
| RemeGen Co., Ltd. | 1 |
| RenJi Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-Muscle Invasive Bladder Neoplasms | 13 |
| Urinary Bladder Neoplasms | 4 |
| Carcinoma in Situ | 2 |
| Carcinoma, Transitional Cell | 1 |
| Neoplasms | 1 |
| Pseudomonas Infections | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.